Gene · 132
Papers2,830
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,830
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Target Class Profiling of Small-Molecule Methyltransferases. | ACS Chem Biol | 2023 | 36976909 | PubTator, text mining | PubMed |
| ShigaPass: an in silico tool predicting Shigella serotypes from whole-genome sequencing assemblies. | Microb Genom | 2023 | 36951906 | PubTator, text mining | PubMed |
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine. | Haematologica | 2023 | 36951168 | PubTator, text mining | PubMed |
| A swapped genetic code prevents viral infections and gene transfer. | Nature | 2023 | 36922599 | PubTator, text mining | PubMed |
| The role of the ATP-adenosine axis in ischemic stroke. | Semin Immunopathol | 2023 | 36917241 | PubTator, text mining | PubMed |
| Adenylate Kinase Fused to Spidroin as a Catalyst for Decreasing Leakage out of 3D-Bioprinted Hydrogels and for ATP Regeneration. | Biomacromolecules | 2023 | 36913719 | PubTator, text mining | PubMed |
| The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy. | Front Immunol | 2023 | 36911717 | PubTator, text mining | PubMed |
| Healthcare workers´ experiences and perceptions of the provision of health insurance benefits to the elderly in rural Tanzania: an explorative qualitative study. | BMC Public Health | 2023 | 36890474 | PubTator, text mining | PubMed |
| Astrocyte-neuron circuits in epilepsy. | Neurobiol Dis | 2023 | 36868484 | PubTator, text mining | PubMed |
| Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC. | Mol Oncol | 2023 | 36852704 | PubTator, text mining | PubMed |
| Plant Defense and Viral Counter-Defense during Plant-Geminivirus Interactions. | Viruses | 2023 | 36851725 | PubTator, text mining | PubMed |
| Investor intention, investor behavior and crypto assets in the framework of decomposed theory of planned behavior. | Curr Psychol | 2023 | 36845208 | PubTator, text mining | PubMed |
| Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant. | Comput Biol Chem | 2023 | 36842392 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of Breast Tumor-Educated Macrophages Revealed by NMR Metabolomics. | Cancers (Basel) | 2023 | 36831553 | PubTator, text mining | PubMed |
| Application of Multilocus Sequence Typing for the Characterization of Leptospira Strains in Malaysia. | Trop Med Infect Dis | 2023 | 36828484 | PubTator, text mining | PubMed |
| Purinergic signaling: A gatekeeper of blood-brain barrier permeation. | Front Pharmacol | 2023 | 36825149 | PubTator, text mining | PubMed |
| Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitus. | Ann Transl Med | 2023 | 36819540 | PubTator, text mining | PubMed |
| An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1. | Br J Cancer | 2023 | 36810913 | PubTator, text mining | PubMed |
WITHDRAWN: Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage). | Adv Redox Res | 2023 | 36776420 | PubTator, text mining | PubMed |
| Molecular Property Prediction of Modified Gedunin Using Machine Learning. | Molecules | 2023 | 36770791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/132/papers?page=12